Life Science Washington, an independent, non-profit trade association serving the life sciences industry in the state of Washington, notes Jubilant HollisterStier's win as...
Jubilant HollisterStier CMO is making significant strides in expanding its capabilities to meet global demand for complex formulations and sterile injectables. In this...
In June of 2023, Chris Preti, CEO of Jubilant HollisterStier CMO, met with Grant Playter, associate editor of Pharmtech.com, at the 2023 DCAT Week conference. Topics of...
On March 16 2023, Contract Pharma sat down and interviewed Chris Preti, when he was appointed as president of Jubilant HollisterStier. Chris Preti has more than 25 years of...
On July 14 2021, Fierce Pharma reported on the $76Mn expansion of the Jubilant HollisterStier CDMO facility in Montreal, Canada. This investment doubled the facility’s drug...
In March 2021, during the height of the COVID-19 pandemic, Contract Pharma wrote an article detailing Jubilant HollisterStier’s contract with Eli Lilly to manufacture a...
